SCOPUS 정보 검색 플랫폼

Psychopharmacology

Volumn 231, Issue 22, 2014, Pages 4417-4418

Ketamine's effectiveness in unipolar versus bipolar depression

(2) Fond, Guillaume a,c Boyer, Laurent b

a UNIVERSITÉ PARIS EST CRÉTEIL (France)

b HÔPITAL SAINTE MARGUERITE (France)

c Hopital Albert Chenevier (France)

Author keywords

[No Author keywords available]

Indexed keywords

KETAMINE; ANESTHETIC AGENT; ANTIDEPRESSANT AGENT;

BIPOLAR DEPRESSION; CLINICAL RESEARCH; DRUG EFFICACY; HUMAN; INTERDISCIPLINARY COMMUNICATION; LETTER; MAJOR DEPRESSION; TEAMWORK; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT;

ANESTHETICS, DISSOCIATIVE; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; HUMANS; KETAMINE;

EID: 84919623595 PISSN: 00333158 EISSN: 14322072 Source Type: Journal
DOI: 10.1007/s00213-014-3773-1 Document Type: Letter

Times cited : (5)

References (6)

1
- 77955891255
- A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression
- 20679587 1:CAS:528:DC%2BC3cXhtV2rtrvK 3000408
- Diazgranados N, Ibrahim L, Brutsche NE, Newberg A, Kronstein P, Khalife S et al (2010) A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 67(8):793-802
- (2010) Arch Gen Psychiatry , vol.67 , Issue.8 , pp. 793-802
- Diazgranados, N.¹ Ibrahim, L.² Brutsche, N.E.³ Newberg, A.⁴ Kronstein, P.⁵ Khalife, S.⁶

2
- 84888364305
- Revised standards for statistical evidence
- 24218581 1:CAS:528:DC%2BC3sXhvFemtbbI 3845140
- Johnson VE (2013) Revised standards for statistical evidence. Proc Natl Acad Sci U S A 110(48):19313-19317
- (2013) Proc Natl Acad Sci U S A , vol.110 , Issue.48 , pp. 19313-19317
- Johnson, V.E.¹

3
- 84919398586
- A randomized controlled trial of intranasal ketamine in major depressive disorder
- Lapidus KA, Levitch CF, Perez AM, Brallier JW, Parides MK, Soleimani L et al (2014) A randomized controlled trial of intranasal ketamine in major depressive disorder. Biol Psychiatry
- (2014) Biol Psychiatry
- Lapidus, K.A.¹ Levitch, C.F.² Perez, A.M.³ Brallier, J.W.⁴ Parides, M.K.⁵ Soleimani, L.⁶

4
- 84919882503
- A comment on Fond and colleagues' systematic review and meta-analysis of ketamine in the treatment of depressive disorders (Psychopharmacology 2014)
- McGirr A, Berlim MT (2014) A comment on Fond and colleagues' systematic review and meta-analysis of ketamine in the treatment of depressive disorders (Psychopharmacology 2014). Psychopharmacology (Berl)
- (2014) Psychopharmacology (Berl)
- McGirr, A.¹ Berlim, M.T.²

5
- 84882943183
- Overlapping meta-analyses on the same topic: Survey of published studies
- 23873947
- Siontis KC, Hernandez-Boussard T, Ioannidis JP (2013) Overlapping meta-analyses on the same topic: Survey of published studies. BMJ 347:f4501
- (2013) BMJ , vol.347 , pp. 4501
- Siontis, K.C.¹ Hernandez-Boussard, T.² Ioannidis, J.P.³

6
- 78751701060
- The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS
- 21232924 1:CAS:528:DC%2BC3MXhtlSkt7w%3D 3061550
- Valentine GW, Mason GF, Gomez R, Fasula M, Watzl J, Pittman B et al (2011) The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS. Psychiatry Res 191(2):122-127
- (2011) Psychiatry Res , vol.191 , Issue.2 , pp. 122-127
- Valentine, G.W.¹ Mason, G.F.² Gomez, R.³ Fasula, M.⁴ Watzl, J.⁵ Pittman, B.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.